Similarly, CXCR2 expression was identified as a poor prognostic marker in lung cancer [41], pancreatic ductal adenocarcinoma [42], and colorectal cancer [43]. The gene discussed is CXCR2; the disease is pancreatic ductal adenocarcinoma.